Table of Contents
Journal of Cancer Research
Volume 2015, Article ID 492782, 4 pages
http://dx.doi.org/10.1155/2015/492782
Research Article

Hepatocellular Carcinoma Is the Most Frequent Final Diagnosis of Focal Liver Lesions Identified in a Cross-Sectional Evaluation of Patients with Chronic Liver Disease in Saudi Arabia

1Department of Medicine, Armed Forces Hospital Southern Region, Khamis Mushayt, Saudi Arabia
2Department of Medicine, Jersey General Hospital, The Parade, St. Helier, Jersey, Channel Isles JE1 3QS, UK
3Gastroenterology Unit, Department of Internal Medicine, IRCCS Azienda Ospedaliera Universitaria San Martino-IST, University of Genoa, 16132 Genoa, Italy
4Department of Radiology, King Fahad Hospital, Armed Forces Hospital Southern Region, Khamis Mushayt, Saudi Arabia

Received 17 September 2014; Accepted 16 December 2014

Academic Editor: Daizo Yoshida

Copyright © 2015 Adnan Agha et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Mittal and H. B. El-Serag, “Epidemiology of hepatocellular carcinoma: consider the population,” Journal of Clinical Gastroenterology, vol. 47, no. 1, pp. S2–S6, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. L. Bolondi, U. Cillo, M. Colombo et al., “Position paper of the Italian Association for the Study of the Liver (AISF): the multidisciplinary clinical approach to hepatocellular carcinoma,” Digestive and Liver Disease, vol. 45, no. 9, pp. 712–723, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. V. Santi, D. Buccione, A. di Micoli et al., “The changing scenario of hepatocellular carcinoma over the last two decades in Italy,” Journal of Hepatology, vol. 56, no. 2, pp. 397–405, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. F. Trevisani, M. C. Cantarini, J. R. Wands, and M. Bernardi, “Recent advances in the natural history of hepatocellular carcinoma,” Carcinogenesis, vol. 29, no. 7, pp. 1299–1305, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. V. Santi, F. Trevisani, A. Gramenzi et al., “Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival,” Journal of Hepatology, vol. 53, no. 2, pp. 291–297, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. E. G. Giannini, A. Cucchetti, V. Erroi, F. Garuti, F. Odaldi, and F. Trevisani, “Surveillance for early diagnosis of hepatocellular carcinoma: how best to do it?” World Journal of Gastroenterology, vol. 19, no. 47, pp. 8808–8821, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. E. Caturelli, F. Bartolucci, E. Biasini et al., “Diagnosis of liver nodules observed in chronic liver disease patients during ultrasound screening for early detection of hepatocellular carcinoma,” The American Journal of Gastroenterology, vol. 97, no. 2, pp. 397–405, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. J. E. Naschitz, E. Zuckerman, N. Elias, and D. Yeshurun, “Primary hepatosplenic lymphoma of the B-cell variety in a patient with hepatitis C liver cirrhosis,” The American Journal of Gastroenterology, vol. 89, no. 10, pp. 1915–1916, 1994. View at Google Scholar · View at Scopus
  9. E. Caturelli, S. Fusilli, L. Costarelli et al., “Focal ultrasound lesions in cirrhotic liver diagnosed as regenerative nodules by biopsy: a morphometric analysis,” Journal of Clinical Gastroenterology, vol. 17, no. 1, pp. 67–72, 1993. View at Publisher · View at Google Scholar · View at Scopus
  10. F. Fornari, C. Filice, G. L. Rapaccini et al., “Small ( 3 cm) hepatic lesions: results of sonographically guided fine-needle biopsy in 385 patients,” Digestive Diseases and Sciences, vol. 39, no. 10, pp. 2267–2275, 1994. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Seitz, C. Greis, A. Schuler et al., “Frequency of tumor entities among liver tumors of unclear etiology initially detected by sonography in the noncirrhotic or cirrhotic livers of 1349 patients: results of the DEGUM multicenter study,” Ultraschall in der Medizin, vol. 32, no. 6, pp. 598–603, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. J. Blessmann, N. D. Khoa, L. V. An, and E. Tannich, “Ultrasound patterns and frequency of focal liver lesions after successful treatment of amoebic liver abscess,” Tropical Medicine and International Health, vol. 11, no. 4, pp. 504–508, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. K. R. Reddy, “Benign and Solid tumors of the liver: relationship to sex, age, size of tumors, and outcome,” American Surgeon, vol. 67, no. 2, pp. 173–178, 2001. View at Google Scholar · View at Scopus
  14. E. A. Ayoola and M. O. Gadour, “Hepatocellular carcinoma in Saudi Arabia: Role of hepatitis B and C infection,” Journal of Gastroenterology and Hepatology, vol. 19, no. 6, pp. 665–669, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. B. Fashir, V. Sivasubramaniam, S. Al Momen, and H. Assaf, “Pattern of liver disease in a Saudi patient population: a decade of experience at security forces hospital, Riyadh, KSA,” Saudi Journal of Gastroenterology, vol. 2, pp. 50–52, 1996. View at Google Scholar
  16. A. Fani, I. Fani, B. Eshratie, P. Samadian, P. Fani, and Y. Gorishi, “Screening for hepatocellular carcinoma in hepatitis B and C chronic carriers in Iran,” Indian Journal of Gastroenterology, vol. 26, no. 6, pp. 297–298, 2007. View at Google Scholar · View at Scopus
  17. F. M. Sanai, S. Sobki, K. I. Bzeizi et al., “Assessment of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma in Middle Eastern patients,” Digestive Diseases and Sciences, vol. 55, no. 12, pp. 3568–3575, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. E. G. Giannini, F. Farinati, and F. Trevisani, “Alpha-fetoprotein in hepatocellular carcinoma surveillance: wake not the dead,” Hepatology, vol. 54, no. 1, pp. 376–377, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. E. G. Giannini, V. Erroi, and F. Trevisani, “Effectiveness of α-fetoprotein for hepatocellular carcinoma surveillance: the return of the living-dead?” Expert Review of Gastroenterology and Hepatology, vol. 6, no. 4, pp. 441–444, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. M. Sherman, “Current status of alpha-fetoprotein testing,” Gastroenterology and Hepatology, vol. 7, no. 2, pp. 113–114, 2011. View at Google Scholar · View at Scopus
  21. E. G. Giannini, G. Sammito, F. Farinati et al., “Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: implications for its clinical use,” Cancer, vol. 120, pp. 2150–2157, 2014. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. M. M. El-Tonsy, H. M. Hussein, T. E.-S. Helal, R. A. Tawfik, and K. M. Koriem, “Schistosoma mansoni infection: is it a risk factor for development of hepatocellular carcinoma?” Acta Tropica, vol. 128, no. 3, pp. 542–547, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. M. A. Hamed and S. A. Ali, “Non-viral factors contributing to hepatocellular carcinoma,” World Journal of Hepatology, vol. 5, no. 6, pp. 311–322, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. A. A. Abdo, F. M. Sanai, and F. Z. Al-Faleh, “Epidemiology of viral hepatitis in Saudi Arabia: are we off the hook,” Saudi Journal of Gastroenterology, vol. 18, no. 6, pp. 349–357, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. M. H. Ismail, “Nonalcoholic fatty liver disease and type 2 diabetes mellitus: the hidden epidemic,” The American Journal of the Medical Sciences, vol. 341, no. 6, pp. 485–492, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. E. G. Giannini and F. Trevisani, “Surveillance for hepatocellular carcinoma: just do it!,” The American Journal of Gastroenterology, vol. 108, no. 6, pp. 1013–1014, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. E. G. Giannini, F. Farinati, and F. Trevisani, “Adequate interval for hepatocellular carcinoma surveillance,” American Journal of Gastroenterology, vol. 108, no. 1174, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus